Parallel vs Manus AI
Side-by-side comparison of AI visibility scores, market position, and capabilities
Paris France YC W24 AI medical coding and admin agents for hospitals; $3.5M seed Apr 2025 led by Frst with Paul Meta/McKinsey and Thomas CTO adapting to fragmented hospital software competing with Nuance for healthcare admin automation.
About
Parallel is a Paris, France-based AI healthcare administration platform — backed by Y Combinator (W24) with $3.5 million in seed funding in April 2025 led by Frst with Y Combinator — providing hospitals and healthcare providers with vertical AI agents that automate time-consuming administrative tasks, starting with medical coding, using generative AI that streamlines hospital operations, improves billing accuracy, and reduces the administrative workload on medical staff — allowing clinicians to focus on patient care rather than documentation and coding compliance. Founded in 2024 by Paul Lafforgue (Meta/McKinsey background) and Thomas Sohet (CTO), with Yago as a co-founder, Parallel's 6-person Paris team designs AI agents that adapt to real-world hospital environments and fragmented software stacks.
General-purpose autonomous AI agent. $125M+ revenue run rate. Acquired by Meta for $2B+ (Dec 2025). Founded 2022, China/Singapore. MIT Innovators Under 35.
About
Manus AI is a general-purpose autonomous AI agent developed by Butterfly Effect Pte Ltd, founded in 2022 by Yichao "Peak" Ji and Xiao Hong. Relocated from China to Singapore (mid-2025). Launched March 6, 2025, autonomously handling complex tasks like market research, coding, data analysis, and content creation without human intervention.
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.